ArticleTherapeutic advances in medical oncology2018

STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer.

Ilaria Attili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.